Physician profile

Jason Liu

Cardiovascular Disease · Walnut Creek, CA

NPI 1770945909

$24,931.63

in general payments reported to CMS, 2019-2025

46 companies · $13K in 2025

The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,835.57
Consulting Fee$5,580.00
Travel and Lodging$1,764.37
Education$79.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alnylam Pharmaceuticals INC. $4,194.83 2024-2025 Amvuttra
Novartis Pharmaceuticals Corporation $4,173.20 2021-2025
Biotronik INC. $2,743.54 2022-2025 Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx
Actelion Pharmaceuticals US, INC. $2,068.26 2020-2025 Opsumit, Uptravi, Opsynvi
Abbott Laboratories $1,688.46 2025 Amplatzer Amulet, Triclip, Dragonfly Opstar
Novo Nordisk INC $1,306.25 2023-2025 Wegovy, Ozempic, Rybelsus
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $1,286.24 2020-2025 Lifevest
Boehringer Ingelheim Pharmaceuticals, INC. $1,032.10 2020-2025 Jardiance
Astrazeneca Pharmaceuticals LP $912.62 2019-2025 Wainua, Farxiga
Amgen INC. $669.30 2019-2025 Repatha, Repatha
Boston Scientific Corporation $563.41 2019-2025 Watchman Flx, Farapulse, Lux-Dx Insertable Cardiac Monitor
Pfizer INC. $414.23 2019-2025
Astellas Pharma US INC $328.06 2020-2021
Janssen Pharmaceuticals, INC $312.01 2020-2024 Xarelto
E.R. Squibb & Sons, L.L.C. $306.61 2020-2025 Camzyos, Eliquis
Show all 46 companies
CompanyGeneral paymentsYearsTop products
Atricure, INC. $283.39 2022-2025 Atriclip Laa Exclusion System
Merck Sharp & Dohme LLC $260.79 2022-2025 Verquvo
Chiesi USA, INC. $230.11 2020-2021
Regeneron Healthcare Solutions, INC. $190.37 2019
Medtronic Vascular, INC. $171.49 2019
Impulse Dynamics (USA) INC. $168.02 2022
Medtronic, INC. $162.23 2021
Surmodics, INC. $133.79 2023 Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy
Esperion Therapeutics, INC. $128.50 2021-2025 Nexletol
Lundbeck LLC $113.36 2020-2021
Lexicon Pharmaceuticals, INC. $111.44 2023-2024 Inpefa
Bayer Healthcare Pharmaceuticals INC. $107.54 2024-2025
Edwards Lifesciences Corporation $102.74 2024-2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Irhythm Technologies, INC. $100.74 2022-2024 Zio Xt Patch, Zio Monitor
Cathworks, INC. $98.73 2020
Sanofi-Aventis U.S. LLC $94.77 2019-2024
Kestra Medical Technology Services, INC. $65.58 2024 Assure Wcd
Heartflow, INC. $53.76 2022-2025 Ffrct
Baxter Healthcare $47.44 2024-2025 Hillrom - Carnation Ambulatory Monitor
Kiniksa Pharmaceuticals International, Plc $46.16 2024 Arcalyst
Biohaven Pharmaceutical Holding Company LTD. $41.58 2022
Bridgebio Pharma, INC. $31.95 2025 Attruby
Philips North America LLC $25.90 2024 (5050) Ext Holter
Shockwave Medical, INC $25.58 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Cleerly, INC. $25.10 2025 Cleerly Ischemia, Cleerly Labs
Daiichi Sankyo INC. $24.30 2023 Injectafer
Kiniksa Pharmaceuticals, LTD. $22.26 2023 Arcalyst
Scpharmaceuticals INC. $18.30 2024
Getinge USA Sales, LLC $17.24 2020
Biosense Webster, INC. $15.22 2020
Abiomed $14.13 2024 Impella

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jason Liu

$24,931.63

in general payments reported 2019-2025

Years
2019-2025
Top company
Alnylam Pharmaceuticals INC.
Context
The $13K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/7216245/jason-liu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.